ASH: Beam’s Base Editor Efficacy In Sickle Cell Disease Holds Up
Next-Gen Program Aims To ESCAPE Busulfan Conditioning
Beam presented data from three more patients than during its last update for BEAM-101, showing stem cell engraftment and efficacy consistent with the first four patients.
